UT2GM151890

Increasing Idea State Biomedical Entrepreneurship via Ecosystem, Enterprises & Experts - Summary

The proposed desired program consists of university and private sector partnerships to deliver a comprehensive program that will engage and support biomedical innovators in the early stages of technology commercialization. By addressing key bottlenecks in the startup process as identified both in the solicitation and by the Driven Accelerator Hub.

According to Driven's Voice of Customer interviews regarding challenges to the commercialization of biomedical innovations, there are 3 main barriers to translating basic science products that benefit patients. First, there is a gap in funding between basic research and validation studies required for early-stage development. Second, there is a lack of knowledge and understanding by innovators about how technologies are brought to market. And third, there is a lack of access to sufficient technology development and commercialization resources.

The creation of the Idea State program is clear evidence of the need for resources not only to cultivate biomedical research but to spur on the commercialization of the new technology created. Correctly identifying deficiencies in the commercialization pathway and preemptively providing corrective measures will create better entrepreneurs and increase the likelihood of commercialization.

Our team will develop a rigorous and engaging online curriculum to support the goals and bridge the gap of sufficient training and knowledge for innovators through a high-availability, scalable, on-demand platform. The platform will help both new and experienced innovators to focus on areas of need and provide direct learning interventions from ideation to market assessment and go-to-market strategies. It will also allow for live mentoring and coaching interactions online to support and supplement the curriculum.

Data and advanced insights will be analyzed for both the overall program and the learning process that will yield trends as to the correlation between innovators who are deemed successful and the parts of the program leveraged most. This will allow us to continuously improve the program, resulting in a more robust education, an increase in the number of biomedical entrepreneurs, an increase in the number of biomedical startups developing market-driven technologies applying for SBIR/STTR, and accessing existing ecosystem resources. It will also lead to increased connectivity between innovative technologies and other enterprises and experts.

The specific aims align participants and establish the desired organization with deliverables that include team governance criteria and processes, and innovator roadmaps for Delaware, Northeast, and wider region/Idea States. They also include the launch of final program and outreach campaigns (local > Northeast) and programming using data obtained through pilot activities, testing the revenue model and pricing for sustainability, as well as increased reach of the launch outreach campaign to the Northeast and national venue.

Insitehub

THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.

93.859 - Biomedical Research and Research Training

National Institute of General Medical Sciences (NIGMS) [HHS - NIH]

Newark, Delaware 197115442 United States

Single Zip Code

Limited Competition: IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) (PAR-22-254)

Amendment Since initial award the End Date has been extended from 07/31/24 to 07/31/26 and the total obligations have increased 1074% from $273,567 to $3,211,105.